Immunocompromised Host

"Immunocompromised Host" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.

Descriptor ID	D016867
MeSH Number(s)	G12.470
Concept/Terms	Immunocompromised Host Immunocompromised Host Host, Immunocompromised Hosts, Immunocompromised Immunocompromised Hosts Immunocompromised Patient Immunocompromised Patients Patient, Immunocompromised Patients, Immunocompromised Immunosuppressed Host Host, Immunosuppressed Hosts, Immunosuppressed Immunosuppressed Hosts

Below are MeSH descriptors whose meaning is more general than "Immunocompromised Host".

Biological Sciences [G]
Immune System Phenomena [G12]
Immunocompromised Host [G12.470]

Below are MeSH descriptors whose meaning is more specific than "Immunocompromised Host".

Immunocompromised Host
Radiation Chimera

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Immunocompromised Host" by people in this website by year, and whether "Immunocompromised Host" was a major or minor topic of these publications.

Bar chart showing 97 publications over 28 distinct years, with a maximum of 9 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	2	1	3
1999	1	0	1
2000	1	3	4
2001	2	1	3
2002	2	2	4
2003	4	2	6
2004	2	1	3
2005	1	1	2
2006	0	1	1
2007	0	1	1
2008	2	1	3
2009	1	5	6
2010	0	1	1
2011	4	5	9
2012	1	0	1
2013	3	2	5
2014	3	2	5
2015	3	4	7
2016	0	2	2
2017	1	4	5
2018	0	2	2
2019	3	5	8
2020	2	2	4
2021	2	2	4
2022	0	2	2
2023	0	1	1
2024	0	3	3

Below are the most recent publications written about "Immunocompromised Host" by people in Profiles.

Leblond AL, Helmchen B, Ankavay M, Lenggenhager D, Jetzer J, Helmchen F, Yurtsever H, Parrotta R, Healy ME, P?schel A, Markkanen E, Semmo N, Ferri? M, Cocquerel L, Seeger H, Hopfer H, M?llhaupt B, Gouttenoire J, Moradpour D, Gaspert A, Weber A. HEV ORF2 protein-antibody?complex deposits are associated with glomerulonephritis in hepatitis E with reduced immune status. Nat Commun. 2024 10 14; 15(1):8849.

View in: PubMed
O'Donnell-Cappelli M, Mandel J, Elder A, Banner L, Nikbakht N. Increased Risk of Postoperative Complications in Organ Transplant Recipients Undergoing Mohs Micrographic Surgery. Dermatol Surg. 2025 02 01; 51(2):139-143.

View in: PubMed
Lazarevic B, Casola AR, Chambers CV. COVID-19 mRNA Vaccination Trends Among Immunocompromised Patients. J Am Board Fam Med. 2024 01 05; 36(6):927-932.

View in: PubMed
Sun G, Weiss A, Zhao J, Silver M, DeMaio M, Dehbashi S. Isolated cerebral Mucormycosis and Aspergillosis coinfection in an immunocompromised adult. BMJ Case Rep. 2023 Aug 27; 16(8).

View in: PubMed
Blazoski C, Kirupaharan P, Hilton R, Leong R, Baram M. Outcomes of extracorporeal membrane oxygenation in immunosuppressed vs. Immunocompetent patients. Heart Lung. 2023 Mar-Apr; 58:179-184.

View in: PubMed
Kato TS, Gomi H, Eisen HJ, Hunt SA. How to preserve information equity for COVID-19 vaccination among severely immunocompromised populations: Challenges among heart transplant recipients in Japan. Clin Transplant. 2022 09; 36(9):e14765.

View in: PubMed
Vuille-Lessard ?, Montani M, Bosch J, Semmo N. Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. J Autoimmun. 2021 09; 123:102710.

View in: PubMed
Winthrop KL, Loftus EV, Baumgart DC, Reinisch W, Nduaka CI, Lawendy N, Chan G, Mundayat R, Friedman GS, Salese L, Thorpe AJ, Su C. Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme. J Crohns Colitis. 2021 Jun 22; 15(6):914-929.

View in: PubMed
Abrahamowicz AA, Chow EJ, Child DD, Dao A, Morrison ED, Gill SK, Rogers DM, Garvin K. Disseminated Histoplasmosis in a Patient With Multiple Sclerosis Treated With Fingolimod. Neurol Neuroimmunol Neuroinflamm. 2021 05; 8(3).

View in: PubMed
Mostyka M, Shia J, Neumann WL, Whitney-Miller CL, Feely M, Yantiss RK. Clinicopathologic Features of Varicella Zoster Virus Infection of the Upper Gastrointestinal Tract. Am J Surg Pathol. 2021 02 01; 45(2):209-214.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement